Vanda Pharmaceuticals buy Cantor Fitzgerald
Start price
30.10.25
/
50%
€3.82
Target price
30.10.26
€9.47
Performance (%)
64.92%
Price
09.02.26
€6.30
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald for Vanda Pharmaceuticals has seen massive gains of 64.92%. This prediction currently runs until 30.10.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vanda Pharmaceuticals | -3.817% | -3.817% |
| iShares Core DAX® | 0.754% | -1.027% |
| iShares Nasdaq 100 | -2.859% | -4.266% |
| iShares Nikkei 225® | 4.946% | 5.736% |
| iShares S&P 500 | -1.254% | -2.357% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals (NASDAQ:VNDA) had its price target lowered by analysts at Cantor Fitzgerald from $13.00 to $11.00. They now have an "overweight" rating on the stock.
Ratings data for VNDA provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Vanda Pharmaceuticals
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€3.56
14.05.25
14.05.25
€11.62
14.05.26
14.05.26
76.97%
09.02.26
09.02.26
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€5.25
01.08.24
01.08.24
€12.05
01.08.25
01.08.25
-31.81%
02.08.25
02.08.25